Afobazole is a benzimidazole derivative classified as an anxiolytic agent, primarily indicated for the treatment of anxiety disorders, panic attacks, and neurosis by enhancing GABAergic neurotransmission.… Read more





Afobazole is a benzimidazole derivative classified as an anxiolytic agent, primarily indicated for the treatment of anxiety disorders, panic attacks, and neurosis by enhancing GABAergic neurotransmission. To support pharmaceutical research and manufacturing, this category offers a range of high-quality reference standards essential for analytical testing and quality control. Researchers and laboratories utilize these compounds, including the active ingredient itself, its dihydrochloride salt, and key structural impurities such as 4-(2-chloroethyl)morpholine and 5-ethoxy-2-mercaptobenzimidazole, to ensure the accuracy of method validation and regulatory compliance. Furthermore, the inclusion of stable isotope labelled compounds, such as Afobazole-d4, provides critical internal standards for precise quantitative analysis, particularly when performing impurity profiling or monitoring drug degradation products. These materials are fundamental tools for maintaining rigorous standards in the assessment of potency, purity, and stability within the development lifecycle of this therapeutic agent.